Division of Plastic Surgery, Department of Surgery, Columbia University Irving Medical Center, New York, NY, USA.
Division of Cardiac, Thoracic, and Vascular Surgery, Department of Surgery, Columbia University Irving Medical Center, New York, NY, USA.
J Plast Reconstr Aesthet Surg. 2024 Nov;98:301-308. doi: 10.1016/j.bjps.2024.09.016. Epub 2024 Sep 10.
Aortic vascular graft/endograft infection (VGEI) has historically been managed through graft removal and re-replacement, but new approaches suggest vascularized tissue transfer is an effective adjunctive treatment. We describe our experience with treating thoracic aortic vascular graft infection with combined omental and bilateral pectoralis major myocutaneous (PMM) advancement flaps.
Data from all patients undergoing combined flap closure by the senior author at a high-acuity cardiac surgery center from 1995-2023 were reviewed. Patients with clinical and radiographic signs of thoracic aortic vascular graft infection were included.
Complete data were available for 598 patients with sternal and mediastinal wounds. Combined PMM and omental flaps were mobilized in 11 thoracic aortic vascular graft infection patients. Indications for flap management included culture-positive infection (8/11; 72.7%), dehiscence (5/11; 45.5%), drainage (7/11; 63.6%), and inability to close the sternotomy due to hemodynamic instability (5/11; 45.5%). During chest exploration, 6/11 (54.5%) underwent complete removal of the infected graft, compared to 5/11 (45.5%) who underwent graft-preserving washout and debridement. Immediate flap closure was performed in 6/11 (54.5%). Postoperative complications included dehiscence (2/11; 18.2%), seroma (1/11; 9.1%), hematoma (1/11, 9.1%), abdominal hernia (1/11; 9.1%), and recurrent infection (1/11; 9.1%). One patient (9.1%) died within 30 days of sternal reconstruction from mitral valve failure tachyarrhythmia. None of the patients underwent reoperation for flap-related complications.
Despite significant comorbidities, low postoperative morbidity and mortality indicate that combined omental and pectoralis major flaps are a safe and effective adjunctive treatment to the antimicrobial and surgical management of select thoracic aortic vascular graft infections.
主动脉血管移植物/腔内移植物感染(VGEI)既往通常通过移植物切除和再置换来治疗,但新方法表明血管化组织转移是一种有效的辅助治疗方法。我们描述了使用联合网膜和双侧胸大肌肌皮瓣治疗胸主动脉血管移植物感染的经验。
回顾了自 1995 年至 2023 年期间,一位高敏心脏手术中心的资深作者对所有接受联合皮瓣闭合的患者的数据。纳入了有胸主动脉血管移植物感染的临床和影像学征象的患者。
有 598 例胸骨和纵隔伤口的患者有完整的数据。11 例胸主动脉血管移植物感染患者中,游离了胸大肌肌皮瓣和网膜瓣。皮瓣处理的指征包括:培养阳性感染(8/11;72.7%)、裂开(5/11;45.5%)、引流(7/11;63.6%)和因血流动力学不稳定而无法闭合胸骨切开术(5/11;45.5%)。在胸部探查时,6/11(54.5%)患者进行了感染移植物的完全切除,而 5/11(45.5%)患者则进行了保留移植物的冲洗和清创术。6/11(54.5%)患者立即进行皮瓣闭合。术后并发症包括裂开(2/11;18.2%)、血清肿(1/11;9.1%)、血肿(1/11;9.1%)、腹部疝(1/11;9.1%)和复发性感染(1/11;9.1%)。1 例(9.1%)患者在胸骨重建后 30 天内死于二尖瓣衰竭心动过速。没有患者因皮瓣相关并发症而再次手术。
尽管存在明显的合并症,但较低的术后发病率和死亡率表明,联合网膜和胸大肌皮瓣是一种安全有效的辅助治疗方法,适用于选择的胸主动脉血管移植物感染的抗菌和手术治疗。